Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Some fans found that while they were waiting to buy Oasis tickets, the prices had quietly crept up from £135 ($177) to £350 ($460).
Days after Brent crude oil prices fell under $74 per barrel, the member nations of OPEC+ agreed to delay a production increase for two months.
Copyright issues make it difficult to substitute creative labor in game development, one expert said.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Data from two promising vaccine trials heralded potential breakthroughs in the treatment of pneumococcal infection and Lyme disease.
Early data this year suggests back-to-school season spending is either flat from last year, or took a slight dip.
After a dismal start to the summer, the movie business roared back to life with a steady stream of big-screen hits.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Danish company Lego reported generating $4.65 billion in revenue for the first half of 2024, up 13% from a year earlier.
A couple of China-based EV giants had good news to share in spite of a weakened consumer at home and fresh tariffs from the EU and Canada.
Mizuho found that both low- and high-income Americans alike are trying to get as thrifty as possible, reducing spend.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.